Greenberg D D, Som P, Meinken G E, Sacker D F, Atkins H L
Nuklearmedizin. 1977 Feb;16(1):26-9.
99MTc-pertechnetate distribution studies were performed in rabbits and mice following pretreatment between 5--336 hours with various routinely used stannous complexes (HSA, MAA, GHT, DTPA, PYPs) containing different amounts of Sn++ (0.17--15.0 mu mg/kg). Beyond a concentration of 0.26 mu mg/kg of Sn++ an alteration in 99mTc-ertechnetate distribution was observed. The red blood cell was found to be the most prominent target. An in-vivo reduction of 99mTc-pertechnetate apparently occurred by the presence of stannous ion within the red blood cell. Preloading time period between 5--24 hours did not alter the uptake of RBC/plasma ratio. Beyond that period it decreased slowly and still persisted up to 2 weeks following pretreatment. RBC/plasma ratio of 99mTcO4-increased with increased Sn++ content of various commercially available pharmaceutical kits.
在用含不同量二价锡(0.17 - 15.0微克/千克)的各种常规使用的亚锡配合物(人血清白蛋白、微球白蛋白、葡庚糖酸盐、二乙三胺五乙酸、焦磷酸盐)预处理5 - 336小时后,对家兔和小鼠进行了高锝[⁹⁹ᵐTc]酸盐分布研究。当二价锡浓度超过0.26微克/千克时,观察到高锝[⁹⁹ᵐTc]酸盐分布发生改变。发现红细胞是最主要的摄取部位。红细胞内二价锡离子的存在显然导致了体内高锝[⁹⁹ᵐTc]酸盐的还原。5 - 24小时的预加载时间段并未改变红细胞/血浆摄取比值。超过该时间段后,该比值缓慢下降,且在预处理后2周仍持续存在。随着各种市售药盒中二价锡含量的增加,高锝酸根离子的红细胞/血浆比值升高。